Effects of a High-Fiber Diet on Hepatocyte Apoptosis and Liver Regeneration After Partial Hepatectomy in Rats With Fatty Liver

Abstract

Background: The morbidity and mortality that accompany fatty liver may occur as a result of increased apoptosis of hepatocytes and decreased liver regeneration. We determined the effects of a high-fiber diet on hepatocyte apoptosis and liver regeneration after partial hepatectomy in rats with fatty liver. Methods: Fatty liver was induced in male Wistar rats weighing around 200 g through feeding of a high-fat diet for 4 weeks. The rats were then randomly assigned to 3 groups that received a high-fat diet, a normal diet, or a high-fiber diet for another 4 weeks. Partial hepatectomy (around 70%) was performed, and rats were killed 6, 24, 48, or 72 hours after hepatectomy. We then measured (1) the ratio of remnant liver weight to body weight and assessed the histology of the remnant liver as indicators of fatty liver, (2) caspase-3 activity and in situ cell death detection of DNA fragmentation as indicators of apoptosis, and (3) 5-bromo-2-deoxyuridine (BrdU) activity and (4) ornithine decarboxylase (ODC) contents in remnant livers as markers of regeneration. Results: We found that (1) a high-fat diet for 4 weeks can markedly induce fatty liver, (2) apoptosis of hepatocytes is greater in fatty liver than in normal liver (98 ± 19 vs 36 ± 7) at 6 hours after partial hepatectomy (p< .05), (3) the capacity of liver regeneration decreases significantly (BrdU index: 30 ± 5 vs 12 ± 3, and ODC contents: 604± 48 vs 390 ± 42 mg/dL) in fatty liver 24 hours after partial hepatectomy (p < .05), (4) a normal diet can partially reverse the effects of fatty liver; (5) a high-fiber diet can significantly reverse the effects of fatty liver (p < .05). Conclusions: A high-fiber diet can reverse the negative effects of fatty liver on apoptosis and regenerative capacity after partial hepatectomy.

Fatty liver can be induced by a high-fat diet and may increase the apoptosis of hepatocytes and decrease liver regeneration after partial hepatectomy. A high-fiber diet can reverse fatty liver and reverse the negative effects of fatty liver on apoptosis and liver regeneration.

Get full access to this article

View all access options for this article.

References

Clarke SD. Nonalcoholic steatosis and steatohepatitis: molecular mechanism for polyunsaturated fatty acid regulation of gene transcription.Am J Physiol. 2001;281:G865– G869.

Gerloff BJ. Dry cow management for the prevention of ketosis and fatty liver in dairy cows. Vet Clin North Am. 2000 ;16:283– 292.

Behrns KE, Tsiotos GG, De Souza NF, Krishna MK, Ludwig J, Nagomey DM. Hepatic steatosis as a potential risk factor for major hepatic resection.J Gastrointest Surg. 1998 ;2:292– 298.

Chamuleau RAFM, Bosman DK. Liver regeneration.Hepatogastroenterology. 1988 ;35:309– 312.

Michalopoulos GK, DeFrances MC. Liver regeneration.Science. 1997;276:60– 66.

Lai HS, Chen WJ, Chen KM. Changes in T-lymphocyte subpopulations and serum lymphokine concentrations after partial hepatectomy in rats.Nutrition. 1996;12:700– 705.

Lai HS, Chen Y, Chen WJ. Carnitine contents in remnant liver, kidney and skeletal muscle after partial hepatectomy in rats: randomized trial. World J Surg. 1998 ;22:42– 47.

Picard C, Lambotte L, Starkel P, et al. Steatosis is not sufficient to cause an impaired regenerative response after partial hepatectomy in rats.J Hepatol. 2002;36:645– 652.

Hussein O, Szvalb S, Van den Akker-Berman LM, Assy N. Liver regeneration is not altered in patients with nonalcoholic steatohepatitis (NASH) when compared to chronic hepatitis C infection with similar grade of inflammation. Dig Dis Sci. 2002 ;47:1926– 1931.

10.

Torbenson M, Yang SQ, Liu HZ, Huang J, Gage W, Diehl AM. STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers. Am J Pathol. 2002 ;161:155– 161.

11.

Farrell GC, Robertson GR, Leclercq I, Horsmans Y. Liver regeneration in obese mice with fatty livers: does the impairment have relevance for other types of fatty liver disease? Hepatology. 2002 ;35:731– 732.

12.

Bursch W, Oberhammer F, Schulte-Hermann R. Cell death by apoptosis and its protective role against disease. Trends Pharmacol Sci. 1992 ;13:245– 251.

13.

Yang S, Lin H, Diehl AM. Fatty liver vulnerability to endotoxin-induced damage despite NF-kappaB induction and inhibited caspase 3 activation. Am J Physiol. 2001 ;281:G382– G392.

14.

Musso G, Gambino R, De Michieli F, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003 ;37:909– 916.

15.

Barber AE, Jones WG, Minei JP, et al. Glutamine or fiber supplementation of a defined formula diet: impact on bacterial translocation, tissue composition, and response to endotoxin. JPEN J Parenter Enteral Nutr. 1990;14:335– 343.

16.

Higgins GM, Anderson RM. Experimental pathology of the liver.Arch Pathol. 1931;12:186– 192.

17.

Nango R, Terada C, Tsukamoto I. Jun N-terminal kinase activation and upregulation of p53 and p21 ^WAF1/CIP1 in selenite-induced apoptosis of regenerating liver. Eur J Pharmacol. 2003;471:1– 8.

18.

Gratzner HG. Monoclonal antibody to 5-bromo- and 5-incode-oxyurine: a new reagent for detection of DNA replication. Science. 1982 ;218:475– 476.

19.

Schipper RG, Rutten RG, Sauerbeck M, et al. Preparation and characterization of monoclonal antibodies against ornithine decarboxylase.J Immunol Methods. 1993 ;161:205– 215.

20.

Brunt EM. Nonalcoholic steatohepatitis: definition and pathology.Semin Liver Dis. 2001;21:3– 16.

21.

Li Z, Yang S, Lin H, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease.Hepatology. 2003;37:343– 350.

22.

Kushner RF. Medical management of obesity. Semin Gastrointest Dis. 2002;13:123– 132.

23.

Lindblad A, Glaumann H, Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999 ;30:1151– 1158.

24.

Itoh H, Ohshima S, Shumiya S, Sakaguchi E. Development of a diet for long-term raising of F344 rats: relationship between dietary digestible crude protein content and digestible energy content. Exp Anim. 2002 ;51:317– 326.

25.

Barzilai N, She L, Liu BQ, et al. Surgical removal of visceral fat reverses hepatic insulin resistance. Diabetes. 1999 ;48:94– 98.

26.

Ye JM, Iglesias MA, Watson DG, et al. PPAR alpha/gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol. 2003 ;284:E531– E540.

27.

Carey DG, Jenkins AB, Campbell LV, Freund J, Chisholm DJ. Abdominal fat and insulin resistance in normal and overweight women: direct measurements reveal a strong relationship in subjects at both low and high risk of NIDDM.Diabetes. 1996;45:633– 638.

28.

Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001 ;50:1844– 1850.

29.

Schiffrin EL, Amiri F, Benkirane K, Iglarz M, Diep QN. Peroxisome proliferator-activated receptors: vascular and cardiac effects in hypertension. Hypertension. 2003 ;42:664– 668.

30.

Matteoni C, Younossi ZM, McCullough A. Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity.Gastroenterology. 1999;116:1413– 1419.

31.

Crespo J, Cayon A, Fernandez-Gil P, et al. Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients. Hepatology. 2001 ;34:1158– 1163.

32.

Petersen KF, Oral EA, Dufour S, et al. Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.J Clin Invest. 2002;109:1345– 1350.

33.

Baroni GS, Marucci L, Benedetti A, Mancini R, Jezequel AM, Orlandi F. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. J Hepatol. 1994;20:508– 513.

34.

Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med. 2000 ;20:1467– 1476.

35.

Faloon WW. Hepatobiliary effects of obesity and weight-reducing surgery. Semin Liver Dis. 1988 ;8:229– 236.

36.

Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A. 1997 ;94:2557– 2562.

37.

Susca M, Grassi A, Zauli D, et al. Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis. Dig Liver Dis. 2001 ;33:768– 777.

38.

Ohnishi H, Muto Y, Maeda T, et al. Natural killer cell may impair liver regeneration in fulminant hepatic failure. Gastroenterol Jpn. 1993;28:40– 44.

39.

Vujanovic NL, Polimeno L, Azzarone A, et al. Changes of liver-resident NK cells during liver regeneration in rats. J Immunol. 1995;154:6324– 6338.

40.

McGowan JA, Fausto N. Ornithine decarboxylase activity and the onset of deoxyribonucleic acid synthesis in regenerating liver. Biochem J. 1977;170:123– 127.

41.

Kahn D, Svanas G, Eagon P, et al. Effect of an antiandrogenic H2 receptor antagonist on hepatic regeneration in rats. J Lab Clin Med. 1998;112:232– 239.

42.

Yang SQ, Lin HZ, Mandal AK, Huang J, Diehl AM. Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology. 2001 ;34:694– 706.